The use of methadone in the treatment of chronic non-malignant pain in an outpatient setting;Metadon til behandling af kroniske ikkemaligne smerter

Ugeskrift for Laeger

Volumn 169, Issue 17, 2007, Pages 1568-1572

  Bendiksen, Anette ^a   McGehee, Eva ^a   Handberg, Gitte ^a  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 34247862336     PISSN: 00415782     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Morley JS. New perspectives in our use of opioids. Pain Forum 1999;8:200-5.
2. Gorman AL, Elliott KJ, Inturrisi CE. The d- and l- isomers of methadone bind to the non-competetive site on the N-methyl-D-aspartate (NMDA) receptor in rat forebrain and spinal cord. Neuroscience Letters 1997;223:5-8.
3. Hagen NA, Wasylenko E. Methadone: outpatient titration and monitoring strategies in cancer patients. J Pain Sympt Management 1999;18:369-75.
4. Scholes CF, Gonty N, Trotman IF. Methadone titration in opioid-resistant cancer pain. Eur J Cancer Care 1999;8:26-9.
5. Taylor WF, Finkel AG, Robertson KR et al. Methadone in the treatment of chronic nonmalignant pain: a 2-year follow-up. Pain Med 2000;1:254-9.
6. Breivik H. Opioids in cancer and chronic non-cancer pain therapy - indications and controversies. Acta Anaesthesiol Scand 2001;45:1059-66.
7. Rhodin A, Grönbladh, Nilsson LH et al. Methadone treatment of chronic non-malignant pain and opioid dependence - a long-term follow up. Eur J Pain 2006;10:271-8.
8. Fishbain DA, Cutler RB, Cole B et al. Medico-legal rounds: medico-legal issues and alleged breaches of "standards of medical care" in opioid rotation to methadone: a case report. Pain Med 2003;4:195-201.
9. Lawlor PG, Turner KS, Hanson J et al. Dose ratio between morphine and methadone in patients with cancer pain. Cancer 1998;2:1167-73.
10. Ripamonti C, Groff L, Brunelli C et al. Switching from morphine to oral methadone in treating cancer pain: what is the equianalgesic dose ratio? J Clin Oncol 1998;16:3216-21.
11. Bruera E, Pereira J, Watanabe S et al. Opioid rotation in patients with cancer pain. Cancer 1996;78:852-7.
12. Jackson KC, Stanford B. Opioid pharmacotherapy in terminal disease. Pain Practice 2004;4:30-8.
13. Eriksen J. Opioidbehandling af langvarige/kroniske non-cancer smertetilstande. Rationel Farmakoterapi 2005;5:1-7.
14. Borgland SL. Acute opioid receptor desensitization and tolerance: is there a link? Clin Exp Pharm Physiol 2001;28:147-54.
15. Kalso E, Allan L, Dellemijn PLI et al. Recommendations for using opioids in chronic non-cancer pain. Eur J Pain 2003;7:381-6.
16. Mao J, Mayer DJ. Spinal cord neuroplasticity following repeated opioid exposure and its relation to pathological pain. Ann N Y Acad Sci 2005:175-84.
17. Barkin RL, Barkin S. The role of venlafaxine and duloxetine in the treatment of depression with decremental changes in somatic symptoms of pain, chronic pain, and the pharmacokinetics and clinical considerations of duloxetine pharmacotherapy. Am J Therap 2005;12:431-8.
18. Fishman SM, Wilsey B, Mahajan G et al. Methadone reincarnated: novel clinical applications with related concerns. Pain Med 2002;3:339-48.